Recro Pharma CEO J Enloe's 2022 pay jumps 107% to $2.3M
Recro Pharma reports 2022 executive compensation
By ExecPay News
Published: April 6, 2023
Recro Pharma reported fiscal year 2022 executive compensation information on April 6, 2023.
In 2022, two executives at Recro Pharma received on average a compensation package of $1.8M, a 8% increase compared to previous year.
Average pay of disclosed executives at Recro Pharma
J. David Enloe, Jr, Chief Executive Officer, received $2.3M in total, which increased by 107% compared to 2021. 33% of Enloe's compensation, or $750K, was in stock awards. Enloe also received $400K in bonus, $499K in option awards, $572K in salary, as well as $50K in other compensation.
Ryan D. Lake, Chief Financial Officer, received a compensation package of $1.4M, which decreased by 39% compared to previous year. 31% of the compensation package, or $438K, was in salary.
Related executives
You may also like
Source: SEC filing on April 6, 2023.